ArticleActa pharmacologica Sinica2026
Graph-based deep learning approach for high-throughput protein-DNA interaction scoring.
Article in Acta pharmacologica Sinica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurately quantifying protein-DNA interactions (PDIs) is critical for understanding biological processes and facilitating drug design. However, the inherent flexibility of nucleic acids limits the availability of experimentally determined structures of PDI complexes, posing a significant challenge for training reliable scoring functions (SFs). To address this, we developed PDIScore, a novel deep learning-based SF for PDI prediction. PDIScore utilizes a comprehensive graph representation to capture nucleotide flexibility, employs a scalable GraphGPS architecture with BigBird linear global attention to handle large interaction interfaces, and leverages Mixture Density Networks (MDNs) to model residue-nucleotide distance distributions. PDIScore was trained on a self-collected dataset of ~7000 protein-nucleic acid complex structures and validated on three rigorous test sets for evaluating its screening, docking, and ranking capabilities. The results illustrated that PDIScore significantly outperformed existing methods: it achieved the best screening power on the screening set (e.g., EF
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.